Dr. Steelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Cooper St
Fort Worth, TX 76104Phone+1 682-885-7960Fax+1 682-885-1327
Summary
- Joel W. Steelman, M.D. grew up a military brat on the move every three to four years to a new home in a different state. Nevertheless, his family roots remained in Texas where he finished high school and attended Texas A&M University both for his undergraduate and medical degrees.
During his second year of medical school, Dr. Steelman realized he had a passion for caring for children. He joined the U.S. Air Force while in medical school and worked as a general pediatrician for four years after completing his pediatric residency. His work with diabetic children, as well as encouragement from endocrine mentors, sparked his decision to leave the military and pursue endocrine subspecialty training.
He trained in pediatric endocrinology at the University of Colorado Children's Hospital, where the magnificent setting turned Dr. Steelman into a lifelong outdoor sport enthusiast, with a strong desire to lead a healthy life. He regularly returns to the West with family and enjoys hiking, skiing, and mountain biking.
While in Colorado, Dr. Steelman developed an interest in care and research in the area of bone disorders, and he began to treat children with osteogenesis imperfecta, or brittle bone disease - a rare, crippling malady. After completing his endocrinology training, He left the West to enter academic medicine at Vanderbilt Children's hospital in Nashville, Tennessee, continuing his work in patient care, teaching, and research.
The desire to be closer to family brought Dr. Steelman back home to Texas in 2008 to Cook Children's. The growth in the endocrine team has allowed him to expand his emphasis in care of special pediatric endocrine populations in subspecialty clinics including the endocrine bone health clinic, endocrine cancer survivor clinic, growth clinic, and Life After Cancer program.
Outside of Cook Children's, Dr. Steelman is involved in pediatric endocrine advocacy and education. He serves on the board of directors for the non-profit organizations.
Education & Training
- University of ColoradoFellowship, Pediatric Endocrinology, 1998 - 2001
- Keesler Medical CenterResidency, Pediatrics, 1991 - 1994
- Texas A&M; Health Science Center College of MedicineClass of 1991
Certifications & Licensure
- TX State Medical License 1992 - 2026
- TN State Medical License 2001 - 2008
- CO State Medical License 1998 - 2001
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency Start of enrollment: 2023 Nov 05
Roles: Contact
- Study to Assess Dose, Efficacy and Safety of Setrusumab in Participants With Osteogenesis Imperfecta Start of enrollment: 2022 Feb 21
- Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Start of enrollment: 2023 Jun 14
- Join now to see all
Publications & Presentations
PubMed
- 35 citationsEfficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman
The Journal of Clinical Endocrinology and Metabolism. 2022-06-16 - 94 citationsRisk factors associated with glucocorticoid-induced adverse effects in children with severe asthma.Ronina A. Covar, Donald Y.M. Leung, David McCormick, Joel Steelman, Philip Zeitler
The Journal of Allergy and Clinical Immunology. 2000-10-01 - 32 citationsOsteoporosis in PediatricsJoel Steelman, Philip Zeitler
Pediatrics in Review. 2001-02-01
Press Mentions
- Childhood Obesity: Food to AvoidMarch 13th, 2017
- FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone DeficiencyJune 29th, 2023
- Once-Weekly Pediatric Growth Hormone Snags FDA ApprovalJuly 5th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: